We are live on ! Find out more
EHI

Eagle Health Investments Portfolio holdings

AUM $603M
1-Year Est. Return 111.06%
This Fund
S&P 500
This Quarter Est. Return
+6.94%
1 Year Est. Return
+111.06%
3 Year Est. Return
+240.87%
5 Year Est. Return
+290.92%
10 Year Est. Return
–
AUM
$291M
AUM Growth
+$36.7M
Cap. Flow
+$21.1M
Cap. Flow %
7.25%
Top 10 Hldgs %
61.7%
Holding
31
New
6
Increased
13
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
AMWL icon
American Well
AMWL
+$10.5M
2
DXCM icon
DexCom
DXCM
+$7.84M
3
OM icon
Outset Medical
OM
+$4.52M
4
INSP icon
Inspire Medical Systems
INSP
+$3.69M
5
PRVA icon
Privia Health
PRVA
+$3.54M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$9.56M
2
AGIO icon
Agios Pharmaceuticals
AGIO
+$6.66M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$3.83M
4
IQV icon
IQVIA
IQV
+$3.44M
5
NTRA icon
Natera
NTRA
+$532K

Sector Composition

Rank Sector Weight
1 Healthcare 97.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARVN icon
26
Arvinas
ARVN
$588M
$1.77M 0.61%
+23,000
New +$1.6M
LYEL icon
27
Lyell Immunopharma
LYEL
$365M
$1.62M 0.56%
+5,000
New +$1.64M
OLK
28
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$1.38M 0.47%
40,000
– –
FDMT icon
29
4D Molecular Therapeutics
FDMT
$600M
$1.38M 0.47%
57,090
+7,090
+14% +$217K
TMO icon
30
Thermo Fisher Scientific
TMO
$224B
– –
-20,951
Closed -$9.56M
UTHR icon
31
PUT
United Therapeutics
UTHR
$22.1B
– –
-50,000
Closed -$8.36M
1
2

Similar funds

IECM
Intrinsic Edge Capital Management Chicago, Illinois $603M AUM 66.97% 1-Year Est. Return
ERWM
Elk River Wealth Management Denver, Colorado $602M AUM 22.77% 1-Year Est. Return
CIG
Capricorn Investment Group Palo Alto, California $602M AUM 165.22% 1-Year Est. Return
JHCP
Jackson Hole Capital Partners Tulsa, Oklahoma $605M AUM 22.77% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
OCAM
Onex Canada Asset Management Toronto, Ontario, Canada $601M AUM 15.16% 1-Year Est. Return
GP
GSK plc London $599M AUM

Eagle Health Investments's Q2 2021 Portfolio in Review

As of Q2 2021, Eagle Health Investments held 31 positions worth $291M, up 14% from $255M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eagle Health Investments deployed $21.1M of net new capital in Q2 2021, opening 6 new positions and adding to 13 existing holdings. Its largest new stake was American Well: 36,380 shares worth $9.15M.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, up from 95% a quarter earlier.

On the sell side, the largest reduction was Agios Pharmaceuticals, an estimated $6.66M trimmed.

  • Eagle Health Investments's largest Q2 2021 buy was American Well: 36,380 shares worth $9.15M.
  • Eagle Health Investments added most to DexCom in Q2 2021, an estimated $7.84M increase.
  • Eagle Health Investments's biggest Q2 2021 reduction was Agios Pharmaceuticals, cutting an estimated $6.66M.
  • Eagle Health Investments fully exited Thermo Fisher Scientific in Q2 2021, selling an estimated $9.56M.
  • Eagle Health Investments's ten largest holdings make up 62% of its $291M portfolio in Q2 2021.
  • Eagle Health Investments opened 6 new positions and closed 2 in Q2 2021.
  • Eagle Health Investments's portfolio value rose 14% quarter-over-quarter to $291M.

Based on Eagle Health Investments's 13F filing for Q2 2021, filed 19 Jul 2021.